Literature DB >> 22013112

The plasticity of regulatory T cell function.

Meenu R Pillai1, Lauren W Collison, Xiaohua Wang, David Finkelstein, Jerold E Rehg, Kelli Boyd, Andrea L Szymczak-Workman, Teresa Doggett, Thomas S Griffith, Thomas A Ferguson, Dario A A Vignali.   

Abstract

Regulatory T cells (T(regs)) can suppress a wide variety of cell types, in diverse organ sites and inflammatory conditions. Whereas T(regs) possess multiple suppressive mechanisms, the number required for maximal function is unclear. Furthermore, whether any interrelationship or cross-regulatory mechanisms exist to orchestrate and control their utilization is unknown. In this study, we assessed the functional capacity of T(regs) lacking the ability to secrete both IL-10 and IL-35, which individually are required for maximal T(reg) activity. Surprisingly, IL-10/IL-35 double-deficient T(regs) were fully functional in vitro and in vivo. Loss of IL-10 and IL-35 was compensated for by a concurrent increase in cathepsin E (Ctse) expression, enhanced TRAIL (Tnfsf10) expression, and soluble TRAIL release, rendering IL-10/IL-35 double-deficient T(regs) functionally dependent on TRAIL in vitro and in vivo. Lastly, whereas C57BL/6 T(regs) are normally IL-10/IL-35 dependent, BALB/c T(regs), which express high levels of cathepsin E and enhanced TRAIL expression, are partially TRAIL dependent by default. These data reveal that cross-regulatory pathways exist that control the utilization of suppressive mechanisms, thereby providing T(reg) functional plasticity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22013112      PMCID: PMC3208127          DOI: 10.4049/jimmunol.1102173

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  Adaptor-related proteins.

Authors:  M S Robinson; J S Bonifacino
Journal:  Curr Opin Cell Biol       Date:  2001-08       Impact factor: 8.382

2.  Approximate variance-stabilizing transformations for gene-expression microarray data.

Authors:  David M Rocke; Blythe Durbin
Journal:  Bioinformatics       Date:  2003-05-22       Impact factor: 6.937

3.  Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Authors:  Christian Mottet; Holm H Uhlig; Fiona Powrie
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

4.  Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.

Authors:  Atsushi Yasukochi; Tomoyo Kawakubo; Seiji Nakamura; Kenji Yamamoto
Journal:  Biol Chem       Date:  2010-08       Impact factor: 3.915

Review 5.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

6.  Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells.

Authors:  I Monleón; M J Martínez-Lorenzo; L Monteagudo; P Lasierra; M Taulés; M Iturralde; A Piñeiro; L Larrad; M A Alava; J Naval; A Anel
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

Review 7.  Plasticity of T reg at infected sites.

Authors:  E Wohlfert; Y Belkaid
Journal:  Mucosal Immunol       Date:  2010-03-17       Impact factor: 7.313

8.  Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation.

Authors:  X R Zhang; L Y Zhang; S Devadas; L Li; A D Keegan; Y F Shi
Journal:  Cell Death Differ       Date:  2003-02       Impact factor: 15.828

9.  Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease.

Authors:  L Gorelik; R A Flavell
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

10.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

View more
  29 in total

Review 1.  T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Authors:  Bruce M Hall
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

Review 2.  Interleukin-35: Expanding Its Job Profile.

Authors:  Deepali V Sawant; Kristia Hamilton; Dario A A Vignali
Journal:  J Interferon Cytokine Res       Date:  2015-04-28       Impact factor: 2.607

Review 3.  Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy.

Authors:  Silvia von Karstedt; Antonella Montinaro; Henning Walczak
Journal:  Nat Rev Cancer       Date:  2017-05-24       Impact factor: 60.716

4.  Comment on "Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathways".

Authors:  Pushpa Pandiyan; Michael Lenardo
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

Review 5.  Once a Treg, always a Treg?

Authors:  Deepali V Sawant; Dario A A Vignali
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

Review 6.  Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells.

Authors:  Pushpa Pandiyan; Jinfang Zhu
Journal:  Cytokine       Date:  2015-07-10       Impact factor: 3.861

Review 7.  Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.

Authors:  Xuefen Li; Xia Liu; Li Tian; Yu Chen
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

8.  Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection.

Authors:  Erik L Brincks; Alan D Roberts; Tres Cookenham; Stewart Sell; Jacob E Kohlmeier; Marcia A Blackman; David L Woodland
Journal:  J Immunol       Date:  2013-03-06       Impact factor: 5.422

9.  Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency.

Authors:  Matthew L Bettini; Fan Pan; Maria Bettini; David Finkelstein; Jerold E Rehg; Stefan Floess; Bryan D Bell; Steven F Ziegler; Jochen Huehn; Drew M Pardoll; Dario A A Vignali
Journal:  Immunity       Date:  2012-05-10       Impact factor: 31.745

10.  TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas.

Authors:  Huanyu Zhang; Guohui Qin; Chaoqi Zhang; Huiyun Yang; Jinyan Liu; Hongwei Hu; Peng Wu; Shasha Liu; Li Yang; Xinfeng Chen; Xueke Zhao; Lidong Wang; Yi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.